Atlas Trials

Velcade, Nipent, Rituxan (VNR) in Subjects With Relapsed Follicular, Marginal Zone, and Mantle Cell Lymphoma

Clinical trial NCT01460602 · WITHDRAWN

Trial details

NCT number
NCT01460602
Sponsor
Louisiana State University Health Sciences Center Shreveport
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Follicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma
Start date
2010-05-01
Primary completion
2014-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.